Dova Pharmaceuticals Announces Hiring of CEO and Presentation at the 35th Annual J.P. Morgan Healthcare Conference

PRESS RELEASE: Dova Pharmaceuticals, Inc., a clinical, late-stage company, having recently completed enrollment in two global, pivotal Phase 3 trials, is pleased to announce the appointment of its new CEO, Alex Sapir. Mr. Sapir will present a corporate...